Sweetgreen, Inc. (SG) Stock Forecast
Data as of Jun 16, 2026Consumer Cyclical · Current price $9.18 (+3.44%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jan 28, 2026 | Christine Cho | Goldman Sachs | $5.60 | -39.0% |
| Jan 20, 2026 | Brian Harbour | Morgan Stanley | $9.00 | -1.9% |
| Jan 7, 2026 | Jeffrey Bernstein | Bernstein | $7.00 | -23.7% |
| Dec 9, 2025 | Logan Reich | RBC Capital | $8.00 | -12.8% |
| Nov 7, 2025 | Brian Mullan | Piper Sandler | $9.00 | -1.9% |
| Nov 7, 2025 | Christine Cho | Goldman Sachs | $5.00 | -45.5% |
| Oct 22, 2025 | Jeffrey Bernstein | Bernstein | $8.00 | -12.8% |
| Oct 21, 2025 | Brian Harbour | Morgan Stanley | $10.00 | +9.0% |
| Oct 16, 2025 | Anthony Trainor | Wells Fargo | $13.00 | +41.7% |
| Apr 14, 2025 | Brian Harbour | Morgan Stanley | $24.00 | +161.6% |
| Aug 19, 2024 | Brian Mullan | Piper Sandler | $39.00 | +325.1% |
| Aug 15, 2024 | Brian Bittner | Oppenheimer | $40.00 | +336.0% |
| Aug 9, 2024 | Brian Bittner | Oppenheimer | $36.00 | +292.4% |
| Jul 17, 2024 | Dennis Geiger | UBS | $31.00 | +237.9% |
| Jul 16, 2024 | Brian Harbour | Morgan Stanley | $25.00 | +172.5% |
| Jun 13, 2024 | Christine Cho | Goldman Sachs | $39.00 | +325.1% |
| Jun 7, 2024 | Christopher Carril | RBC Capital | $45.00 | +390.5% |
| May 13, 2024 | Katherine Griffin | Griffin | $36.00 | +292.4% |
| May 10, 2024 | Christopher Carril | RBC Capital | $35.00 | +281.5% |
| Apr 1, 2024 | Brian Bittner | Oppenheimer | $34.00 | +270.6% |
Top Analysts Covering SG
SG vs Sector & Market
| Metric | SG | Consumer Cyclical Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.89 | 2.52 | 2.41 |
| Analyst Count | 18 | 13 | 19 |
| Target Upside | -21.5% | +387.4% | +17.1% |
| P/E Ratio | 74.29 | 13.82 | 31.98 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-28 | $700M | $709M | $717M | 10 |
| 2027-03-28 | $174M | $177M | $180M | 4 |
| 2027-06-28 | $204M | $207M | $211M | 4 |
| 2027-09-28 | $195M | $198M | $201M | 4 |
| 2027-12-28 | $178M | $181M | $184M | 4 |
| 2028-03-28 | $196M | $200M | $203M | 3 |
| 2028-06-28 | $229M | $233M | $236M | 3 |
| 2028-09-28 | $219M | $223M | $226M | 3 |
| 2028-12-28 | $207M | $211M | $214M | 3 |
| 2029-12-28 | $875M | $890M | $906M | 6 |
| 2030-12-28 | $959M | $976M | $994M | 3 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-28 | $-0.77 | $-0.72 | $-0.58 | 7 |
| 2027-03-28 | $-0.18 | $-0.18 | $-0.17 | 1 |
| 2027-06-28 | $-0.09 | $-0.09 | $-0.08 | 1 |
| 2027-09-28 | $-0.14 | $-0.14 | $-0.13 | 1 |
| 2027-12-28 | $-0.21 | $-0.21 | $-0.20 | 1 |
| 2028-03-28 | $-0.16 | $-0.16 | $-0.15 | 2 |
| 2028-06-28 | $-0.04 | $-0.04 | $-0.04 | 2 |
| 2028-09-28 | $-0.11 | $-0.10 | $-0.10 | 2 |
| 2028-12-28 | $-0.16 | $-0.16 | $-0.16 | 2 |
| 2029-12-28 | $-0.59 | $-0.58 | $-0.57 | 2 |
| 2030-12-28 | $-0.60 | $-0.59 | $-0.58 | 2 |
Frequently Asked Questions
What is the analyst consensus for SG?
The consensus among 18 analysts covering Sweetgreen, Inc. (SG) is Hold with an average price target of $7.20.
What is the highest price target for SG?
The highest price target for SG is $45.00, set by Christopher Carril at RBC Capital on 2024-06-07.
What is the lowest price target for SG?
The lowest price target for SG is $5.00, set by Christine Cho at Goldman Sachs on 2025-11-07.
How many analysts cover SG?
18 analysts have issued ratings for Sweetgreen, Inc. in the past 12 months.
Is SG a buy or sell right now?
Based on 18 analyst ratings, SG has a consensus rating of Hold (2.89/5) with a -21.5% upside to the consensus target of $7.20.
What are the earnings estimates for SG?
Analysts estimate SG will report EPS of $-0.72 for the period ending 2026-12-28, with revenue estimated at $709M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.